The Latest Breaking News from HIMS

Telehealth stocks have declined from the Covid-induced highs and are expected to plunge further due to the nation’s return to normalcy. Moreover, the current macroeconomic headwinds are expected to put added pressure on telehealth companies Teladoc Health (TDOC), American Well (AMWL), Hims & Hers Health (HIMS), iRhythm Technologies (IRTC), and…

According to Benzinga Pro data, during Q1, Hims & Hers Health (NYSE:HIMS) posted sales of $101.31 million. Earnings were up 47.85%, but Hims & Hers Health still reported an overall loss of $16.25 million.

Hims & Hers Health Inc (NYSE:HIMS) has partnered with healthcare provider Carbon Health to enable access to a broader range of care options through its platform. The partnership will further enable the healthcare company to provide California patients with a better continuum of primary care treatment. The partnership adds the seventh U.S. state…

Hims & Hers Health Inc (NYSE:HIMS) has expanded its skincare collections, including a facial cleanser, moisturizer, daily SPF, spot corrector, and face oil. "We've listened to Hers customers' personal skincare concerns regarding their top skincare recommendations in order to provide the most personalized skincare experience possible, whether one product is used or six,"…

Delhi Chief Minister Arvind Kejriwal on Friday instructed the Health Department to distribute e-Health Cards prior to the implementation of the Health Information Management System (HIMS), which is expected to begin from March 2023.

Despite a significant dip in COVID-19 cases worldwide, the demand for telemedicine is expected to remain strong owing to rising chronic diseases and an aging population. The sheer convenience of telemedicine makes it a popular choice for many consumers. So, Wall Street analysts expect telemedicine stocks Hims & Hers Health…

Rising inflation, supply chain issues, and geopolitical tensions will likely continue to keep the stock market under pressure for the foreseeable future. However, consumer defensive stocks perform relatively well in an inflationary environment. Therefore, Wall Street analysts expect fundamentally sound consumer defensive stocks Coty Inc. (COTY), Hims & Hers (HIMS),…

Hims & Hers Health Inc (NYSE:HIMS) reported fourth-quarter FY21 sales growth of 104% year-on-year, to $84.7 million, beating the consensus of $76.79 million. The average order value for the quarter was $74. Q4 2021 ending member subscriptions grew 95% year-over-year to 609,000. The gross profit margin contracted 400 basis points Y/Y to 73%,…

Hims & Hers Health (NYSE:HIMS) reported its Q4 earnings results on Tuesday, February 22, 2022 at 04:00 PM. Here's what investors need to know about the announcement.